Recombinant Human Mothers against decapentaplegic homolog 1 (SMAD1) - CD BioSciences

service-banner

Recombinant Human Mothers against decapentaplegic homolog 1 (SMAD1)

Recombinant Human Mothers against decapentaplegic homolog 1 (SMAD1)

SPP-04835

Size Price
20 μg Online Inquiry
100 μg Online Inquiry
500 μg Online Inquiry
Target Information
Species Homo sapiens
Target Name SMAD
UniProt No. Q15797
Subcellular Location Cytoplasm, Nucleus
Tissue Specificity Ubiquitous. Highest expression seen in the heart and skeletal muscle.
Gene Abbr. SMAD1
Full Name SMAD family member 1
Alias BSP-1, BSP1, JV4-1, JV41, MADH1
Introduction Transcriptional modulator activated by BMP (bone morphogenetic proteins) type 1 receptor kinase. SMAD1 is a receptor-regulated SMAD (R-SMAD). SMAD1/OAZ1/PSMB4 complex mediates the degradation of the CREBBP/EP300 repressor SNIP1. May act synergistically with SMAD4 and YY1 in bone morphogenetic protein (BMP)-mediated cardiac-specific gene expression.
Product Details
Product Type Recombinant Protein
Storage & Handling
Storage Temp. Store at -20 °C upon receipt unless otherwise instructed.
Handling Aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.

For research use only. Not intended for any clinical use. No products from CD BioSciences may be resold, modified for resale or used to manufacture commercial products without prior written approval from CD BioSciences.